McKesson stock price jumps about 16% after profit forecast raise; MCK rallies in New York trade
McKesson shares soared 16% to $953.43 after the company raised its 2026 profit outlook and beat quarterly earnings estimates. Fiscal Q3 adjusted EPS reached $9.34, topping forecasts, with revenue at $106.16 billion. U.S. pharmaceutical sales rose 9%. The company confirmed plans to spin off its medical-surgical unit by late 2027.